Neglected tropical diseases

Increasing animal vaccines adoption to address livestock losses and boost control of zoonotic diseases

24 April 2019 | Geneva −− Vaccines can effectively prevent diseases in livestock populations and prevent economic losses to thousands of smallholder farmers of Africa, Asia and Latin America who depend on them for their livelihood.

A recent publication outlines strategies that can encourage adoption of animal vaccines by these farmers . It also highlights the important role innovation and the private sector can play to addressing these diseases.

Developing surveillance indicators to measure global progress against pork tapeworm

©Glenn L.

25 January 2019 | Geneva -- The World Health Organization (WHO) is developing a set of indicators to track global progress in controlling Taenia solium (pork tapeworm).

Valid epidemiological data are scarce and knowledge gaps pose a problem to implementing effective control measures.

In order to generate evidence towards better surveillance of the disease and make data available more easily, WHO has recently added global data on T. solium to its Global Health Observatory (GHO).

WHO workshop: visionary plans to scale-up rabies control

© Zilient

14 December 2018 | Geneva –– Representatives from 11 countries recently convened at WHO headquarters to devise plans to end human rabies deaths by 2030.

Visionary plans have been drawn up for rabies elimination in many countries.

The meeting follows the recent announcement by Gavi, the Vaccine Alliance, of a new investment strategy to expand their portfolio to include human rabies vaccines in countries where Gavi runs other vaccine programmes.

Eliminating rabies: potential investment in life-saving vaccines can bolster prospects for zero human rabies deaths

©NAMPA

12 December 2018 | Geneva −− Addressing the high cost associated with human rabies vaccines and making them readily available to populations can save lives, notably children who are frequent victims of dog bites.

Providing equitable access to these vaccines can also have far-reaching implications in strengthening health systems, providing incentives to new actors to enter the market, and accelerating work towards reaching zero human rabies deaths by 2030.